Similar articles

• [Deep venous thrombosis--treatment].

  Fries R, Böhm M. Fries R, et al. Dtsch Med Wochenschr. 2003 May 2;128(18):999-1002. doi: 10.1055/s-2003-38952. Dtsch Med Wochenschr. 2003. PMID: 12721879 German. No abstract available.
• [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].

  Ruiz Manzano J, Monreal M. Ruiz Manzano J, et al. Med Clin (Barc). 1998 Nov 28;111(18):697-9. Med Clin (Barc). 1998. PMID: 9887434 Spanish. No abstract available.
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.

  Hirsh J. Hirsh J. Semin Hematol. 1997 Oct;34(4 Suppl 4):20-5. Semin Hematol. 1997. PMID: 9399406 Review. No abstract available.
• Letters on management of ischemic stroke.

  Porat G. Porat G. Am Fam Physician. 2012 Sep 15;86(6):492. Am Fam Physician. 2012. PMID: 23062038 No abstract available.
• When can the patient with deep venous thrombosis begin to ambulate?

  Aldrich D, Hunt DP. Aldrich D, et al. Phys Ther. 2004 Mar;84(3):268-73. Phys Ther. 2004. PMID: 14984299 Review. No abstract available.